Quiz: Test your insomnia IQInsomnia is a common complaint many physicians hear, and its incidence has only increased since the global pandemic. Test your knowledge on insomnia and its treatment. FDA trims use of contentious Alzheimer's drug amid backlash FDA approval of controversial Alzheimer’s drug could delay discovery of more promising treatments The U.S. Food and Drug Administration recently approved aducanumab, the first treatment that aims to slow the progression of Alzheimer’s disease. But approval of the drug has provoked mixed reactions from the scientific community. FDA approves much-debated Alzheimer's drug panned by experts U.S. government health officials on Monday approved the first new drug for Alzheimer's disease in nearly 20 years, disregarding warnings. Zeposia: new oral treatment for relapsing-remitting multiple sclerosis Third oral sphingosine 1-phosphate receptor modulator to be marketed for MS in Canada. Greater risk of bladder cancer in people with MS: study Ketogenic medium chain triglyceride drink improves cognition in mild cognitive impairment Already available in Europe, Nestlé aims to launch BrainXpert as a Natural Health Product in Canada in 2022. Managing sleep disturbances in Parkinson’s Disease The majority of people with PD experience nonmotor symptoms, such as insomnia, which are often under-recognized and poorly managed. Epidural anesthesia during labour may increase risk of autism spectrum disorders in children Study finds 37% increased risk of autism spectrum disorders, with risk increasing with longer duration of epidural anesthesia. Emgality (galcanezumab) now indicated to reduce cluster headache frequency CGRP binding antibody is first drug approved by Health Canada to help prevent episodic cluster headaches First Previous 27 28 29 30 31 Next Last
